Literature DB >> 24509644

Delayed hypersensitivity reaction after initial dose of infliximab: a case report.

Anna Krajcovicova1, Tibor Hlavaty, Zuzana Zelinkova, Juraj Letkovsky, Martin Huorka.   

Abstract

We report here an unusual case of delayed hypersensitivity reaction in a young woman with ulcerative colitis after the first administration of infliximab (IFX). The patient developed severe serum-sickness-like reaction, and her anti-IFX antibody titer increased rapidly after a single infusion of IFX. The possible reason for the delayed hypersensitivity reaction to a single IFX exposure might be the presensitization of the patient by murine antigens as she had been keeping mice and hamsters as pets for several years.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24509644     DOI: 10.1097/MEG.0000000000000049

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.

Authors:  Tae-Hwan Kim; Shin-Seok Lee; Won Park; Yeong Wook Song; Chang-Hee Suh; SooKyoung Kim; Young Nam Lee; Dae Hyun Yoo
Journal:  Clin Drug Investig       Date:  2020-06       Impact factor: 2.859

2.  Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.

Authors:  Amanda Muir; Lea Surrey; Alyssa Kriegermeier; Ala Shaikhkalil; David A Piccoli
Journal:  Am J Gastroenterol       Date:  2016-03       Impact factor: 10.864

Review 3.  Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors:  Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.